KING OF PRUSSIA, Pa., Oct. 29, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the 2024 Wolfe Research Healthcare Conference in New York, New York on Tuesday, November 19, 2024 at 12:20PM (ET).
A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com). For those unable to listen to the live webcast, replays of the presentation will be available on the Company's website for 90 days following the conference.
Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico.
| Last Trade: | US$196.84 |
| Daily Change: | -0.68 -0.34 |
| Daily Volume: | 422,157 |
| Market Cap: | US$11.560B |
June 07, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
